Bioinformatics startup Iterative Scopes has acquired two clinical trial optimization companies, Clinical Research Strategy Group and Precision Research, to support the drug development process for inflammatory bowel disease (IBD). The acquisition is part of its plans to strengthen ties with the IBD clinical research community and research sites.
Iterative Scopes uses AI-powered computational algorithms to help patients find new treatments faster and help pharmaceutical companies expedite their IBD clinical trials process. The acquisition will help enhance the firm’s knowledge of the research process and accelerate drug development as both clinical trial companies work with a network of clinical research sites and community gastroenterologists across the US, with a focus on optimizing clinical trials for IBD treatments.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.